Paper Chase is a research database designed to offer abstracts of research articles published in journals that have a highly rated impact factor as determined by ISI Impact Factor and PageRank. Abstracts are organized by date, with the most recently published papers listed first. 

Paper Chase

21.

Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial.

Lancet.
Wills AM, Hubbard J, Macklin EA, Glass J, Tandan R, Simpson EP, Brooks B, Gelinas D, Mitsumoto H, Mozaffar T, Hanes GP, Ladha SS, Heiman-Patterson T, Katz J, Lou JS, Mahoney K, Grasso D, Lawson R, Yu H, Cudkowicz M, Wills AM.
| Jun 14, 2014
22.

Cardiomyopathy in children: importance of aetiology in prognosis--authors' reply.

Lancet.
Lipshultz SE, Orav EJ, Wilkinson JD.
| Mar 1, 2014
23.

A need for scalable outpatient palliative care interventions.

Lancet.
Block SD, Billings JA.
| May 17, 2014
24.

Defining success in neoadjuvant breast cancer trials.

Lancet.
Carey LA, Winer EP.
| Jul 12, 2014
26.

80 under 40 by 2020: an equity agenda for NCDs and injuries.

Lancet.
Binagwaho A, Muhimpundu MA, Bukhman G, Asiimwe A.
| Jan 4, 2014
28.

Surgery and global health: a Lancet Commission.

Lancet.
Meara JG, Hagander L, Leather AJ.
| Jan 4, 2014
29.

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials.

Lancet.
Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD, Camm AJ, Weitz JI, Lewis BS, Parkhomenko A, Yamashita T, Antman EM.
| Mar 15, 2014
30.

WHO's new guidelines for antiretroviral treatment - Authors' reply.

Lancet.
Mayer K, Beyrer C.
| Nov 30, 2013
32.

Challenges in clinical trial design for HIV-1 cure research.

Lancet.
Eyal N, Kuritzkes DR.
| Nov 2, 2013
33.

Male hypogonadism.

Lancet.
Basaria S.
| Apr 5, 2014
34.

Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial.

Lancet.
Fuchs CS, Tomasek J, Yong CJ, Dumitru F, Passalacqua R, Goswami C, Safran H, dos Santos LV, Aprile G, Ferry DR, Melichar B, Tehfe M, Topuzov E, Zalcberg JR, Chau I, Campbell W, Sivanandan C, Pikiel J, Koshiji M, Hsu Y, Liepa AM, Gao L, Schwartz JD, Tabernero J, Mendez G.
| Jan 4, 2014
35.

The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective.

Lancet.
Mahmood SS, Levy D, Vasan RS, Wang TJ.
| Mar 15, 2014
36.

Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data.

Lancet.
Steg PG, Bhatt DL, Hamm CW, Stone GW, Gibson CM, Mahaffey KW, Leonardi S, Liu T, Skerjanec S, Day JR, Iwaoka RS, Stuckey TD, Gogia HS, Gruberg L, French WJ, White HD, Harrington RA.
| Dec 14, 2013
37.

Intracranial atherosclerosis.

Lancet.
Qureshi AI, Caplan LR.
| Mar 15, 2014
38.

Delirium in elderly people.

Lancet.
Inouye SK, Westendorp RG, Saczynski JS.
| Mar 8, 2014
39.

Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial.

Lancet.
Wiviott SD, White HD, Ohman EM, Fox KA, Armstrong PW, Prabhakaran D, Hafley G, Lokhnygina Y, Boden WE, Hamm C, Clemmensen P, Nicolau JC, Menozzi A, Ruzyllo W, Widimsky P, Oto A, Leiva-Pons J, Pavlides G, Winters KJ, Roe MT, Bhatt DL.
| Aug 17, 2013
40.

Adult obstructive sleep apnoea.

Lancet.
Jordan AS, McSharry DG, Malhotra A.
| Feb 22, 2014